Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer - Derived cells and regulates paclitaxel IC50

Clinical Cancer Research

Volumn 13, Issue 12, 2007, Pages 3724-3730

  Turturro, Francesco ^a,b   Von Burton, Gary ^a   Friday, Ellen ^a,b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (6 CHLOROMETHYL) 2',7' DICHLORODIHYDROFLUORESCEIN DIACETATE; DICHLORODIHYDROFLUORESCEIN DIACETATE; DISULFIDE; GLUCOSE; INSULIN; PACLITAXEL; REACTIVE OXYGEN METABOLITE; RNA; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; HYPERGLYCEMIA; INHIBITORY CONCENTRATION 50; PACLITAXEL; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIOREDOXIN;

EID: 34250763809     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0244     Document Type: Article

References (43)

1. Turturro F, Friday E, Ye G, et al. Role of hyperglycemia-induced thioredoxin-interacting protein (TXNIP) in metastatic breast cancer [abstract 429]. Proc AACR 2006;47.
2. Schulze PC, Yoshioka J, Takahashi T, et al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004;279:30369-74.
3. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT. The interaction of thioredoxin with Txnip. J Biol Chem 2006;281:21884-91.
4. Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999;274:21645-50.
5. Junn E, Han SH, Im JY, et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000;164:6287-95.
6. Yamawaki H, Berk BC. Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 2005;14:149-53.
7. Nishikawa T, Edelstein D, Du XL, et al. normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787-90.
8. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-5.
9. Muti P. The role of endogenous hormone in the etiology and prevention of breast cancer: the epidemiologic evidence. Ann N Y Acad Sci 2004;1028:273-82.
10. Milazzo G, Giorgino F, Damante F, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992;52:3924-30.
11. Cullen KJ, Yee D, Sly WS, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48-53.
12. Cara JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 1994;42:49-54.
13. Lefrancois-Martinez AM, Martinez A, Antoine B, Raymondjean M, Kahn A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 1995;270:2640-3.
14. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
15. Tome ME, Johnson DBF, Rimsza LM, et al. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 2005;106:3594-601.
16. 4An rat glioma: relation to intratumoral pH reduction and circulatory changes after glucose supply. Int J Radiat Oncol Biol Phys 1995;33:409-16.
17. Canter RJ, Zhou R, Kesmodel SB, et al. Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Ann Surg Oncol 2004;11:265-73.
18. Butler LM, Zhou X, Xu WS, et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002;99:11700-5.
19. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs of enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
20. Shalev A, Pise-Masison CA, Radonovich M, et al. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology 2002;143:3695-8.
21. Minn AH, Hafele C, Shalev A. Thioredoxin-interacting proteinis stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 2005;146:2397-405.
22. Beckner ME, Stracke ML, Liotta LA, Schiffmann E. Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst 1990;82:1836-40.
23. Ikarashi M, Takahashi Y, Yshii Y, Nagata T, Assai S, Ishikawa K. Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res 2002;22:4045-8.
24. 3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 2003;22:4035-46.
25. Nishinaka Y, Nishiyama A, Masutani H, et al. Loss of thioredoxin-binding protein-2/vitamin D3 upregulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res 2004;64:1287-92.
26. Jeon JH, Lee KN, Hwang CH, Kwon KS, You KH, Choi I. Tumor suppressor VDUP1 increases p27 (kip1) stability by inhibiting JAB1. Cancer Res 2005;65:4485-9.
27. Nishinaka Y, Masutani H, Oka S, et al. Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J Biol Chem 2004;279:37559-65.
28. Goldberg SF, Miele ME, Hatta N, et al. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 2003;63:432-40.
29. 3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620. Oncol Rep 2002;9:75-9.
30. Yoshioka J, Schreiter ER, Lee RT. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal 2006;8:2143-51.
31. 3 up-regulated protein 1 (VDUP1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 2002;91:689-95.
32. Wang Y, De Keulenaer GW, Lee RT. Vitamin D(3)-upregulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 2002;277:26496-500.
33. World CJ, Yamawaki H, Berk BC. Thioredoxin in the cardiovascular system. J Mol Med 2006;84:997-1003.
34. Pae HO, Jun CD, Yoo JC, et al. Enhancing and priming of macrophages for superoxide anion production by taxol. Immunopharmacol Immunotoxicol 1998;20:27-37.
35. Wang Y, Chen C, Chung S, et al. Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol 2004;54:322-30.
36. Park S, Wu C, Gordon JD, Zhong X, Emami A, Safa AR. Taxol induces caspase-10-dependent apoptosis. J Biol Chem 2004;279:51057-67.
37. Koizumi K, Matoba R, Ueno N, et al. Prediction of docetaxel response in human breast cancer by gene expression profiling. J Clin Oncol 2005;23:422-31.
38. Kim SJ, Miyoshi Y, Taguchi T, et al. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res 2005;11:8425-30.
39. Yamawaki H, Pan S, Lee RT, Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. JClin Invest 2005;115:733-8.
40. + exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin Cancer Res 2003;9:2366-73.
41. Crown J, O'Leary M. The taxanes: an update. Lancet 2000;355:1176-8.
42. Minn AH, Cuoto FM, Shalev A. Metabolism-independent sugar effects on gene transcription: the role of 3-O-methylglucose. Biochemistry 2006;45:11047-51.
43. Ahsan MK, Masutani H, Yamguchi Y, et al. Loss of interleukin-2-dependency in HTLV-1-infected T cells on gene silencing of thioredoxin-binding protein-2. Oncogene 2006;25:2181-91.